Anders Gottsäter Selected Research

Carotid Stenosis (Carotid Artery Stenosis)

5/2023	Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort study.
1/2022	Circulating Biomarkers Predict Symptomatic but Not Asymptomatic Carotid Artery Stenosis.
1/2021	Pro B-type Natriuretic Peptide and Midregional Proadrenomedullin are Associated with Incident Carotid Stenosis During Long Term Follow-up.
1/2021	Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort study.
2/2010	Coagulation activation and ultrasound characteristics in patients with carotid artery disease.
5/2004	[Surgical interventions also in primary prevention of stroke caused by significant carotid artery stenosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Gottsäter Research Topics

Disease

25	Abdominal Aortic Aneurysm 09/2023 - 12/2008
13	Peripheral Arterial Disease 05/2022 - 07/2010
11	Chronic Limb-Threatening Ischemia 04/2024 - 07/2005
10	Diabetes Mellitus 04/2024 - 01/2016
9	Stroke (Strokes) 05/2023 - 07/2010
9	Hypertension (High Blood Pressure) 01/2020 - 10/2009
8	Neoplasms (Cancer) 09/2023 - 11/2007
8	Atherosclerosis 01/2021 - 03/2010
8	Thrombosis (Thrombus) 01/2020 - 11/2002
7	Inflammation (Inflammations) 01/2020 - 01/2005
6	Carotid Stenosis (Carotid Artery Stenosis) 05/2023 - 05/2004
5	Type 2 Diabetes Mellitus (MODY) 05/2023 - 06/2010
5	Myocardial Infarction 04/2021 - 10/2006
5	Aneurysm (Aneurysms) 12/2020 - 05/2009
5	Venous Thromboembolism 12/2018 - 11/2002
4	Vascular Diseases (Vascular Disease) 01/2023 - 01/2005
4	Obesity 12/2022 - 06/2010
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 02/2007
4	Necrosis 09/2016 - 11/2007
3	Intermittent Claudication 04/2024 - 01/2020
3	Pulmonary Embolism 01/2020 - 11/2002
3	Thrombophilia 05/2019 - 12/2009
2	Ischemia 11/2023 - 12/2016
2	Hemorrhage 01/2021 - 04/2019
2	Ulcer 01/2020 - 02/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 01/2018
2	Aortic Dissection 01/2019 - 07/2018
2	Body Weight (Weight, Body) 03/2016 - 06/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2012 - 01/2005
2	Pathologic Constriction (Stenosis) 02/2010 - 05/2004
1	Rupture 09/2023
1	Coronary Stenosis (Coronary Artery Stenosis) 12/2022
1	Metabolically Benign Obesity 12/2022
1	Carotid Artery Diseases 01/2022
1	Dementia (Dementias) 01/2022
1	Foot Ulcer 10/2021

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2007
7	AnticoagulantsIBA 01/2021 - 11/2002
7	Interleukin-6 (Interleukin 6)IBA 09/2016 - 07/2005
6	C-Reactive ProteinIBA 01/2021 - 07/2005
5	LipidsIBA 12/2016 - 07/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 07/2005
4	proadrenomedullinIBA 01/2021 - 07/2017
4	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2021 - 01/2017
4	HomocysteineIBA 12/2020 - 01/2005
4	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 01/2014
4	Endothelins (Endothelin)IBA 12/2014 - 09/2007
4	Protein CIBA 11/2013 - 05/2009
3	omega-Chloroacetophenone (Mace)IBA 04/2021 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2010
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2018
3	Cystatin CIBA 01/2021 - 07/2017
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 11/2007
3	methylallyl trisulfide (MATS)IBA 05/2019 - 12/2009
3	factor V LeidenIBA 05/2019 - 09/2012
3	Endothelin-1 (Endothelin 1)IBA 09/2016 - 10/2008
3	CD40 Ligand (CD40L)IBA 12/2014 - 07/2005
3	InterleukinsIBA 12/2014 - 05/2009
3	Protein C InhibitorIBA 11/2013 - 05/2009
3	CytokinesIBA 06/2010 - 11/2007
3	Thrombin FDA Link 05/2010 - 02/2010
2	VitaminsIBA 09/2023 - 01/2005
2	HDL CholesterolIBA 12/2022 - 07/2005
2	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2020
2	Clopidogrel (Plavix)FDA Link 01/2021 - 02/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 02/2017
2	RivaroxabanIBA 01/2021 - 02/2017
2	proneurotensinIBA 01/2021 - 07/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2021
2	Peroxidase (Myeloperoxidase)IBA 01/2020 - 11/2007
2	Natriuretic PeptidesIBA 09/2019 - 07/2017
2	AntibodiesIBA 12/2014 - 12/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2011 - 01/2010
2	Apolipoproteins AIBA 04/2010 - 03/2010
2	ApolipoproteinsIBA 04/2010 - 03/2010
2	NeopterinIBA 10/2008 - 07/2005
2	Malondialdehyde (Propanedial)IBA 11/2007 - 01/2005
1	MetalsIBA 10/2023
1	AntioxidantsIBA 09/2023
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2023
1	CalciumIBA 12/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 12/2021
1	ChemokinesIBA 01/2021
1	Atrial Natriuretic Factor (ANF)IBA 01/2021
1	AdrenomedullinIBA 01/2021
1	Apolipoproteins B (ApoB)IBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2023 - 07/2005
10	Surgical Amputation (Amputations) 10/2021 - 07/2010
7	Vascular Surgical Procedures 04/2024 - 02/2019
4	Stents 10/2023 - 10/2008
4	Carotid Endarterectomy 01/2022 - 05/2004
3	Endovascular Aneurysm Repair 07/2018 - 12/2011
2	Secondary Prevention 01/2021 - 02/2017
2	Percutaneous Coronary Intervention 06/2017 - 11/2007
2	Catheters 02/2011 - 10/2008
1	Conservative Treatment 11/2023
1	Drug-Eluting Stents 10/2023
1	Glycemic Control 05/2023
1	Aftercare (After-Treatment) 01/2021